Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 1 027,14 €, with a 24-hour trading volume of 2,22B €. The asset's market cap is 915,95B €, after moving 0.85% in the last day.
Tokenized Eli Lilly And Co is trading at 1 034,66 €, with a tokenized market cap of 40,21M € and a 24-hour trading volume of 1,32M €. The tokenized asset has moved -0.84% in the past 24 hours.